Pharma Journalist -

Lundbeck has received orphan designation from the European Commission for asedebart (Lu AG13909), an experimental monoclonal antibody being developed to treat Cushing’s syndrome of…
Read More...

Takeda has received approval in Japan for ORZEYFUL (oveporexton), a new oral treatment for adults with narcolepsy type 1 (NT1), a rare neurological disorder that causes excessive…
Read More...

GSK has received approval in Japan for Hibsago (bepirovirsen), an antisense oligonucleotide (ASO) treatment designed to provide a functional cure for chronic hepatitis B (CHB) in…
Read More...

Gossamer Bio has entered into an agreement with new and existing institutional investors to raise up to approximately $250 million through a private placement. The funding will support…
Read More...

Genentech, a member of the Roche Group, plans to invest approximately $750 million to build a new device fill-finish manufacturing facility at its campus in Hillsboro, Oregon. The…
Read More...

Piramal Pharma has completed the acquisition of an additional 40.67% stake in Yapan Bio, a Hyderabad-based contract development and manufacturing organization (CDMO) focused on vaccines…
Read More...

Charles River Laboratories and Medigen Vaccine Biologics have entered into a collaboration to support the development of Medigen’s next-generation multivalent enterovirus vaccine.…
Read More...

WellSpan Health and Johns Hopkins Medicine are expanding their oncology collaboration to improve access to advanced cancer care, specialist expertise and clinical research for patients…
Read More...

SandboxAQ has announced the general availability of AQPotency, an AI-powered model designed to help drug discovery teams predict how strongly potential drug molecules may act on disease…
Read More...

Ultragenyx Pharmaceutical has received accelerated approval from the U.S. Food and Drug Administration (FDA) for GENGLYCOS (pariglasgene brecaparvovec-opnr), also known as DTX401, for…
Read More...